glp-1 for dementia Prevention of with Medications: Benefits & Insights Can blockbuster GLP-1 weight loss

The implication is that clinicians managing menopausal women on GLP-1 therapies should consider hormonal status not as a separate clinical question but as a variable that directly shapes metabolic treatment outcomes

The brief examines the rapid growth in marketing of compounded versions of GLP-1 drugs following FDA-declared shortages that began in 2022

Cell Metabol 2020;31:1189 205.e13

The occurrence of more IIA/X hybrid fibers and rare I/IIA hybrid fibers in patients with long COVID suggests that the pathophysiology of long COVID includes a fiber-type shift towards a less oxidative, more glycolytic phenotype